JSPR Jasper Therapeutics, Inc.

2d ago, source: Seeking Alpha

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company’s lead product ...

MLYS Mineralys Therapeutics, Inc.

2d ago, source: Seeking Alpha

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate ...

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection

1mon ago, source: Business Insider

IRVINE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the enrollment of the 12 th participant on March 23, 2024, in the ...

Q4 2023 Inhibikase Therapeutics Inc Earnings Call

27d ago, source: Yahoo Finance

Milton Werner; President & CEO; Inhibikase Therapeutics, Inc. Garth Lees-Rolfe; CFO; Inhibikase Therapeutics, Inc. Operator Ladies and gentlemen, thank you for standing by Greetings and welcome to ...

Axsome Therapeutics Inc AXSM

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Fate Therapeutics, Inc.

18d ago, source: CNN

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno ...

Intellia Therapeutics Inc NTLA

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Coeptis Therapeutics Holdings Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript

22d ago, source: Yahoo Finance

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript March 28, 2024 Inhibikase Therapeutics, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the ...

Intellia Therapeutics, Inc.

6mon ago, source: CNN

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...